Erick Lucera

Filings by Erick Lucera span 3 companies, the busiest being Dyne Therapeutics, Inc., Editas Medicine, Inc. and Beyond Air, Inc. Over a trading history stretching from 16 March 2023 to 13 August 2026, the count stands at 12 filings.

The open-market side counts 2 purchases for €27k alongside 6 sales for €278k. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants. So far in 2026, the count stands at no purchases and 4 sales.

Most recently, on 17 August 2026, the filings show an open-market sale worth €41k in Dyne Therapeutics, Inc. The most recent open-market purchase was published on 15 August 2024, 794 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.